Developing a guidance resource for managing delirium in patients with COVID-19

As the COVID-19 pandemic escalates worldwide, it is apparent that many patients with more severe illness will also experience delirium. These patients pose a particular challenge in the application of optimal care due to issues with infectious risk, respiratory compromise and potential interactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Meagher, David, Adamis, Dimitrios, Timmons, Suzanne, O’Regan, Niamh A, O’Keeffe, Shaun, Kennelly, Sean, Corby, Catherine, Meaney, Anna Maria, Reynolds, Paul, Mohamad, Mas, Glynn, Kevin, O’Sullivan, Roisin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Perspective Piece
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520634/
https://www.ncbi.nlm.nih.gov/pubmed/32460926
http://dx.doi.org/10.1017/ipm.2020.71
_version_ 1783587815352696832
author Meagher, David
Adamis, Dimitrios
Timmons, Suzanne
O’Regan, Niamh A
O’Keeffe, Shaun
Kennelly, Sean
Corby, Catherine
Meaney, Anna Maria
Reynolds, Paul
Mohamad, Mas
Glynn, Kevin
O’Sullivan, Roisin
author_facet Meagher, David
Adamis, Dimitrios
Timmons, Suzanne
O’Regan, Niamh A
O’Keeffe, Shaun
Kennelly, Sean
Corby, Catherine
Meaney, Anna Maria
Reynolds, Paul
Mohamad, Mas
Glynn, Kevin
O’Sullivan, Roisin
author_sort Meagher, David
collection PubMed
description As the COVID-19 pandemic escalates worldwide, it is apparent that many patients with more severe illness will also experience delirium. These patients pose a particular challenge in the application of optimal care due to issues with infectious risk, respiratory compromise and potential interactions between medications that can be used to manage delirium with antiviral and other treatments used for COVID-19. We describe a guidance resource adapted from existing guidelines for delirium management that has been tailored to the specific challenge of managing delirium in patients with COVID-19 infection. Issues around the assessment and treatment of these patients are examined and distilled into a simple (one-paged guidance resource that can assist clinicians in managing suspected delirium.
format Online
Article
Text
id pubmed-7520634
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-75206342020-09-28 Developing a guidance resource for managing delirium in patients with COVID-19 Meagher, David Adamis, Dimitrios Timmons, Suzanne O’Regan, Niamh A O’Keeffe, Shaun Kennelly, Sean Corby, Catherine Meaney, Anna Maria Reynolds, Paul Mohamad, Mas Glynn, Kevin O’Sullivan, Roisin Ir J Psychol Med Perspective Piece As the COVID-19 pandemic escalates worldwide, it is apparent that many patients with more severe illness will also experience delirium. These patients pose a particular challenge in the application of optimal care due to issues with infectious risk, respiratory compromise and potential interactions between medications that can be used to manage delirium with antiviral and other treatments used for COVID-19. We describe a guidance resource adapted from existing guidelines for delirium management that has been tailored to the specific challenge of managing delirium in patients with COVID-19 infection. Issues around the assessment and treatment of these patients are examined and distilled into a simple (one-paged guidance resource that can assist clinicians in managing suspected delirium. Cambridge University Press 2020-05-28 /pmc/articles/PMC7520634/ /pubmed/32460926 http://dx.doi.org/10.1017/ipm.2020.71 Text en © College of Psychiatrists of Ireland 2020 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective Piece
Meagher, David
Adamis, Dimitrios
Timmons, Suzanne
O’Regan, Niamh A
O’Keeffe, Shaun
Kennelly, Sean
Corby, Catherine
Meaney, Anna Maria
Reynolds, Paul
Mohamad, Mas
Glynn, Kevin
O’Sullivan, Roisin
Developing a guidance resource for managing delirium in patients with COVID-19
title Developing a guidance resource for managing delirium in patients with COVID-19
title_full Developing a guidance resource for managing delirium in patients with COVID-19
title_fullStr Developing a guidance resource for managing delirium in patients with COVID-19
title_full_unstemmed Developing a guidance resource for managing delirium in patients with COVID-19
title_short Developing a guidance resource for managing delirium in patients with COVID-19
title_sort developing a guidance resource for managing delirium in patients with covid-19
topic Perspective Piece
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520634/
https://www.ncbi.nlm.nih.gov/pubmed/32460926
http://dx.doi.org/10.1017/ipm.2020.71
work_keys_str_mv AT meagherdavid developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT adamisdimitrios developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT timmonssuzanne developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT oreganniamha developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT okeeffeshaun developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT kennellysean developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT corbycatherine developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT meaneyannamaria developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT reynoldspaul developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT mohamadmas developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT glynnkevin developingaguidanceresourceformanagingdeliriuminpatientswithcovid19
AT osullivanroisin developingaguidanceresourceformanagingdeliriuminpatientswithcovid19

Ejemplares similares